Adriacin and bone marrow depression Patient Reports February 12, 2012

Adriacin Side Effects Report #4565031-X
Adriacin side effect was reported by a Physician from on Jan 13, 2005. Female patient, 41 years of age, was diagnosed with t-cell lymphoma and was treated with Adriacin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, bone marrow depression, central nervous system lymphoma, cerebellar tumour, cerebral haemorrhage, gingival bleeding, haemorrhagic diathesis, myelodysplastic syndrome. Adriacin dosage: 400 MG CUMULATIVE DOSE. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN, CARBOPLATIN, PREDNISOLONE, VINCRISTINE SULPHATE, MITOXANTRONE, CYTARABINE. Patient died on 03/01/2002.

Adriacin Side Effects Report #4551071-3
Adriacin side effect was reported by a Consumer or non-health professional from on Dec 24, 2004. Male patient, 50 years of age, weighting 132.3 lb, was diagnosed with ewing's sarcoma and was treated with Adriacin. After drug was administered, patient experienced the following side effects: blood pressure decreased, bone marrow depression, cancer pain, disseminated intravascular coagulation, malnutrition, metastases to bone, metastases to lymph nodes, metastases to spine. Adriacin dosage: 30 MG (2 CYCLES), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE. Patient recovered.